See All Resources
Angiotensin System Inhibitors May Improve Outcomes of Patients With Castration-Resistant Prostate Cancer During Abiraterone Acetate Treatment—A Cardio-Oncology Study
Go to ResourceLink is copied!
Orginally Published:
March, 31 2021
To access this material, you must be an IC-OS member. Become an IC-OS Member today